Medicine and HealthNature Communications
Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery
Z. Wang, W. Li, et al.
Discover how a novel Chol-modified sphingomyelin lipid bilayer can revolutionize drug delivery! This promising platform, developed by Zhiren Wang, Wenpan Li, Yanhao Jiang, Jonghan Park, Karina Marie Gonzalez, Xiangmeng Wu, Qing-Yu Zhang, and Jianqin Lu, enhances therapeutic efficacy while minimizing premature payload leakage. Explore its potential to significantly improve treatment across various cancer models.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
Ligand-switchable nanoparticles resembling viral surface for sequential drug delivery and improved oral insulin therapy
T. Yang, A. Wang, et al.
Medicine and Health
Non-invasive transdermal delivery of biomacromolecules with fluorocarbon-modified chitosan for melanoma immunotherapy and viral vaccines
W. Zhu, T. Wei, et al.
Medicine and Health
Besifloxacin liposomes with positively charged additives for an improved topical ocular delivery
G. A. D. Santos, R. Ferreira-nunes, et al.
Medicine and Health
Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy
S. Corvigno, Y. Liu, et al.
